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Long-term 
longitudinal study 
of renal failure 
progression
Although the progression of renal 
failure is known to be inexorable, 
the rate of decline of the glomerular 
fi ltration rate (GFR) remains a subject 
of controversy. Previous studies of the 
prognosis of chronic kidney disease 
do not provide a clear answer, as the 
largest epidemiological surveys were not 
longitudinal and the smaller longitudinal 
ones did not provide estimates of change 
in GFR. Importantly, it is necessary 
to prove that patients participating in 
these studies actually have chronic renal 
failure. Th is can be demonstrated by 
persistent decreases in GFR. In a 58,000-
person community in Norway, Eriksen 
and Ingebretsen identifi ed patients with 
low fi ltration rates and ascertained that 
low GFRs remained 3 months later. In 
a subgroup of 3,000 patients, nine had 
low GFRs measured over the follow-up 
period, which averaged 44 months. 
Almost three-fourths of the patients 
had a decline in GFR. Th e cumulative 
incidence of renal failure averaged 0.04%, 
well below what had been previously 
reported. It is worth noting that women 
had a slower rate of renal failure 
progression than did men. See page 375.
Carbon monoxide: 
poison or treatment?
One of the surprising fi ndings of modern 
cell biological research is that carbon 
monoxide (CO), long known as a 
potent toxic gas, is actually produced in 
mammalian tissues and has some potent 
biological eff ects that may be benefi cial 
in important disease settings. CO is 
produced by catabolism of heme by the 
enzyme heme oxygenase-1. Th is enzyme 
is oft en induced in situations of injury, 
especially in ischemia. Several studies 
have shown that infusion of CO reduces 
apoptosis and in fl ammation associated 
with ischemic states in the kidney 
and other organs. One of the major 
problems in kidney transplantation is the 
ischemic injury that the kidney suff ers 
aft er being removed from the donor. 
Several solutions are available that allow 
minimization of this injury, but they 
still require improvement. Sandouka 
et al. delivered low levels of CO to 
isolated perfused rabbit kidneys and 
tested its eff ect on ischemic injury. Th eir 
innovation was to perfuse the kidney 
with compounds that spontaneously 
hydrolyze to release CO under 
physiological conditions of pH and 
temperature. Th e kidneys were fl ushed 
with these solutions and then stored at 
4 °C for 24 hours. Th e perfusion rates, 
glomerular fi ltration rates and sodium 
and glucose absorptive capacities of the 
kidneys were then evaluated. Isolated 
perfused kidneys pre-treated with 
CO-releasing compounds had higher 
rates of perfusion and fi ltration than 
those stored aft er fl ushing with standard 
solutions. Studies of their oxygen 
consumption and mitochondrial 
function also showed excellent 
preservation. Although this study 
will need to be supplemented by in 
vivo methods, it provides a novel and 
intriguing avenue of renal protection. 
See page 239.
Cystatin C as a 
measure of glomerular 
filtration rate
In epidemiological studies, the use of 
serum creatinine has been fraught with 
some diffi  culty. Th ere is a continuing 
need to fi nd a useful substitute, the 
most recent of which is plasma cystatin 
C. Cystatin C is a small protein that 
is fi ltered and degraded completely 
by the proximal tubule in one pass. 
In a study reported in this issue, Rule 
et al. systematically evaluated serum 
creatinine, cystatin C and iothalamate 
clearance (as a measure of GFR) in 460 
adults. Remarkably, the relationship 
between cystatin C and GFR diff ered 
across clinical presentations. Patients 
with kidney disease had the strongest 
correlation between cystatin C and 
GFR, and healthy individuals had a 
weaker correlation. GFR was higher in 
transplant recipients than in patients 
with kidney disease for any given 
cystatin C level. In patients with chronic 
kidney disease, the correlation between 
cystatin C and GFR was slightly higher 
than when the serum creatinine 
equation was used. Th is research 
emphasizes the need for a better marker 
of GFR that requires a single blood test.
See page 399.
Home blood pressure 
measurements in 
renal failure
Th ere is increasing evidence that blood 
pressure measurement in the clinic 
does not refl ect the patient’s actual 
blood pressure. In part this is due to 
the anxiety that patients experience 
when going to clinics. Agarawl and 
Andersen studied home blood pressure 
monitoring as a predictor of renal 
failure. Th ey found that blood pressure 
measured at home was lower than that 
measured in the clinic. Patients were 
followed for more than 3 years. Th e 
development of renal failure or other 
serious end points was correlated with 
either clinic or home blood pressure. To 
test which method of measuring blood 
pressure more accurately predicted 
end-stage renal failure or mortality, the 
authors evaluated the contribution of an 
increase of blood pressure equivalent to 
1 standard deviation of that measured 
in the clinic or at home. Th ey found 
that the increase in event rate (or risk) 
was signifi cantly greater for blood 
pressure measured at home than for 
that measured in the clinic. As risk is 
presumably related to the eff ect of the 
integrated pressure on the circulation, 
these fi ndings demonstrate that 
measurement of blood pressure at home 
is the right way to go. See page 406.
